HARBOR CAPITAL ADVISORS, INC.

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1039128 CHICAGO, IL

Position in BMRN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$912,315

+$659,189 QoQ

Shares Held

15,944

+314.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#288

of 561 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $28,134,645 across 28 Biotechnology names. BMRN ranks #11 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	36,368	$4,170,318
2	VCEL	Vericel Corp	72,852	$3,241,185
3	HALO	Halozyme Therapeutics, Inc.	36,977	$2,894,189
4	RARE	Ultragenyx Pharmaceutical Inc.	72,316	$2,414,631
5	CELC	Celcuity Inc.	19,933	$2,085,390
6	TARS	Tarsus Pharmaceuticals, Inc.	29,612	$1,863,779
7	AGIO	Agios Pharmaceuticals, Inc.	46,550	$1,727,470
8	SRPT	Sarepta Therapeutics, Inc.	92,669	$1,665,261

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$912,315	15,944	+314.0%	Shares	Sole	2026-08-07
2024-12-31	$253,126	3,851	+2.5%	Shares	Sole	2025-01-10
2024-09-30	$264,149	3,758	+0.4%	Shares	Sole	2024-10-29
2024-06-30	$308,161	3,743	+0.3%	Shares	Sole	2024-07-09
2024-03-31	$325,952	3,732	+11.1%	Shares	Sole	2024-05-13
2023-12-31	$323,874	3,359	+0.0%	Shares	Sole	2024-01-08
2023-09-30	$297,115	3,358	0.0%	Shares	Sole	2023-10-20
2023-06-30	$291,071	3,358	0.0%	Shares	Sole	2023-07-11
2023-03-31	$326,531	3,358	—	Shares	Sole	2023-04-26
No filing history on record for this holder in this stock.